6.02.2010

Preview June 3

  1. FDA orders Glaxo, AstraZeneca (AZN:$43.59,00$1.28,003.03%) to make changes,  U.S. health regulators have finalized new warnings for controversial inhaled asthma drugs, but exercised new powers to order the changes on products made by GlaxoSmithKline.
  2. Yahoo Inc (YHOO:$15.18,00$0.16,001.07%)  Steve Case: In 5 Years, Yahoo Will Still Be Significant.
  3. Hovnanian Enterprises Inc.'s (HOV:$6.15,00$0.18,003.02%) fiscal second-quarter loss narrowed more than expected, aided by minimal land charges and stabilizing home prices. 
  4. Applied Signal Technology Inc (APSG:$17.87,00$0.70,004.08%) , a provider of signal intelligence gear, posted quarterly profit above estimates, helped by growth in its broadband communications business.
  5. CBS Corp. (CBS/A:$14.59,00$0.42,002.96%) Chief Executive Les Moonves said Wednesday that advertising sales negotiations in advance of the fall programming season are well underway and the numbers are coming in where he wanted them.
  6. Bank of Ireland (IRE:$5.05, up to 5.20 after hours)
    • Long, no real reason just really like this company.
  7. Amgen Inc (AMGN:$56.09,00$5.33,0010.50%) helped boost the Nasdaq, gaining 10.5 percent to $56.09 after the U.S. Food and Drug Administration approved the sale of its osteoporosis drug to help prevent fractures in post-menopausal women.
  8. Cascade Corporation (CASC:$33.88,00$2.99,009.68%) , a leading international manufacturer of lift truck attachments, forks and accessories, will host a conference call to report first quarter fiscal 2011 results on Monday, June 7, 2010 at 2:00 p.m. PDT.
  9. U.S. oil and natural gas company Noble Energy Inc (NBL:$60.15,00$3.92,006.97%) said on Wednesday it had agreed to sell certain non-core assets for about $550 million and projected annual production growth of 10 percent over the next five years.
  10. Network security systems provider SonicWALL, Inc. (SNWL:$8.99,00$0.27,003.10%) said Wednesday it has agreed to be acquired by an investor group led by private equity firm Thoma Bravo in a deal worth around $717 million.
UPSIDE MOVERS:
  1. CYBX, +6.6%, 17.66 to 20
    • Cyberonics Inc.'s (CYBX:$18.76,00$0.94,005.27%) fiscal fourth-quarter profit jumped 78% on reboundng sales and higher margins as the medical-device company's results topped Wall Street's expectations.
  2. XIDE, +15.9%, 4.01 to 5.27, 
    • Exide Technologies (XIDE:$4.27,00$0.23,005.69%) jumped higher in after-hours trade after reporting better-than-expected Q4 results.
  3. CWTR, +4.4%, 5.90 to 6.45
    • Coldwater Creek Inc (CWTR:$5.94,00$0.04,000.68%) swung to a quarterly profit, helped by better pricing, but continues to grapple with a bloated inventory, which could force the women's apparel retailer to implement deeper markdowns in the second quarter.
  4. HOTT, +0.7%, 5.43 to 5.34
  5. HERO, +10.3%, 2.60 to 2.91
    • Long, The moratorium the President just signed benefit companies like hero, like I said in my blog 3 days ago so I hope you played it, should see alot of upside continuance on this one.
  6. ZLC, +9.4%, 2.58 to 2.74
    • Zale Corp. (ZLC:$2.6000,$-0.0500,-1.89%), up to 2.74 after hours.
DOWNSIDE MOVERS:
  1. CEPH, -1.3%, 59.54 to 56.05
  2. BLUD, flat, 20.09 to 19.22
  3. APSG, -3%, 19.20 to 17.17
  4. HOV, -0.8%, 6.27 to 6.01
  5. ZUMZ, -2.5%, 16.94 to 18.64 
WATCH-LIST MOVERS:
  1. Amylin Pharmaceuticals, Inc. (AMLN:$16.78,00$0.57,003.52%), no real news other than they are presenting at a conference where there boss will do a company overview.
  2. ZymoGenetics, Inc. (ZGEN:$4.215,0$-0.125,0-2.88%) today announced the initiation of the second part of a Phase 2 clinical trial with PEG-Interferon lambda (IL-29) and ribavirin in treatment-of patients with chronic hepatitis C virus (HCV) infection.
  3.  GTx, Inc. (GTXI:$2.33,00$0.25,0012.02%) , announced today that management will present a company overview on June 9 at the Jefferies 2010 Global Life Sciences Conference in New York City. The GTx presentation will begin at 8:30 a.m. Eastern Time. A simultaneous webcast of the presentation will be accessible from the investor relations section of the GTx website at www.gtxinc.com
  4. Market speculation that RadioShack Corp. (RSH:$21.81, up 4%...) is shopping itself around resurfaced again this week just as the consumer electronics chain is asking Fort Worth for $10.76 million in tax breaks to stay put.
  5. Weight Loss Drugs Under Review:
    1. Orexigen Therapeutics,OREX:$5.50 Inc. Announces FDA Acceptance of Contrave® New Drug Application for the Treatment of Obesity.
      • Neither a panel meeting nor a decision date has yet been set.
    2. An advisory panel to the U.S. Food and Drug Administration will review Arena Pharmaceuticals Inc's (ARNA:$3.23,00$0.18,005.90%) weight loss drug lorcaserin at a meeting tentatively scheduled for Sept. 16, the company said.
    3. A separate meeting of the advisory committee, scheduled for July 15, will review a rival weight loss drug, Qnexa, being developed by Vivus Inc (VVUS:$12.80,00$0.60,004.92%) . The FDA has set a deadline of Oct. 28 to reach a final approval decision on Qnexa.
Boomwin Radar's done by at